Annals of Clinical and Translational Neurology (Jun 2022)

Axonal injury in asymptomatic individuals preceding onset of multiple sclerosis

  • Daniel Jons,
  • Henrik Zetterberg,
  • Martin Biström,
  • Lucia Alonso‐Magdalena,
  • Martin Gunnarsson,
  • Magnus Vrethem,
  • Kaj Blennow,
  • Staffan Nilsson,
  • Peter Sundström,
  • Oluf Andersen

DOI
https://doi.org/10.1002/acn3.51568
Journal volume & issue
Vol. 9, no. 6
pp. 882 – 887

Abstract

Read online

Abstract Axonal loss is the main cause of irreversible disability in multiple sclerosis (MS). Serum neurofilament light (sNfL) is a biomarker of axonal disintegration. In this nested case–control study, blood samples from 519 presymptomatic persons (age range 4–39 years) who later received an MS diagnosis showed higher sNfL concentrations than 519 matched controls (p < 0.0001), noticeable at least 10 years before clinical MS onset. Mean values for pre‐MS and control groups were 9.6 pg/mL versus 7.4 pg/mL 0–5 years before onset, and 6.4 pg/mL versus 5.8 pg/mL 5–10 years before onset. These results support that axonal injury occurs early in MS pathogenesis.